Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C>T mutations in critical genes

Oncogene

Volumn 35, Issue 25, 2016, Pages 3342-3350

  Mukhopadhyay, P ^a   Ferguson, B ^a   Muller, H K ^b   Handoko, H Y ^a   Walker, G J ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; PYRIMIDINE DIMER; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; COMPARATIVE STUDY; CONTROLLED STUDY; DEAMINATION; DNA REPLICATION; EXOME; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC BACKGROUND; GENOMIC INSTABILITY; HISTOPATHOLOGY; MALE; MELANOMA; MUTAGENESIS; MUTAGENIC ACTIVITY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; ANIMAL; COPY NUMBER VARIATION; DNA SEQUENCE; GENE TRANSLOCATION; GENETICS; HUMAN; INDEL MUTATION; KAPLAN MEIER METHOD; METABOLISM; MOUSE; NEWBORN; PATHOLOGY; POINT MUTATION; PROCEDURES; RADIATION RESPONSE; SKIN; SKIN TUMOR;

ANIMALS; ANIMALS, NEWBORN; DNA COPY NUMBER VARIATIONS; EXOME; HUMANS; INDEL MUTATION; KAPLAN-MEIER ESTIMATE; MELANOMA; MICE; POINT MUTATION; SEQUENCE ANALYSIS, DNA; SKIN; SKIN NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 84975701699     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.386     Document Type: Article

References (41)

1. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
2. Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet light. Mutat Res 2005; 571: 19-31.
3. Brash DE. UV Signature Mutations. Photochem Photobiol 2015; 91: 15-26.
4. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251-263.
5. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006-1014.
6. Furney SJ, Turajlic S, Fenwick K, Lambros MB, MacKay A, Ricken G et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol 2013; 230: 261-269.
7. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 1994; 91: 360-364.
8. Ouhtit A, Nakazawa H, Armstrong BK, Kricker A, Tan E, Yamasaki H et al. UVradiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst 1998; 90: 523-531.
9. Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 2015; 348: 880-886.
10. Sheppard KE, McArthur GA. The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma. Clin Cancer Res 2013; 19: 5320-5328.
11. Ferguson B, Ram R, Handoko HY, Mukhopadhyay P, Muller HK, Soyer HP et al. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression. Oncogene 2014; 34: 2879-2886.
12. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A et al. Mutational heterogeneity in cancer and the search for new cancerassociated genes. Nature 2013; 499: 214-218.
13. Viros A, Sanchez-Laorden B, Pedersen M, Furney SJ, Rae J, Hogan K et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 2014; 511: 478-482.
14. Metz CH, Scheulen M, Bornfeld N, Lohmann D, Zeschnigk M. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma. Cancer Med 2013; 2: 208-215.
15. Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene 2003; 22: 3113-3122.
16. Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza' P et al. p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med 2013; 210: 581-603.
17. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL et al. Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature 2011; 469: 548-553.
18. Wolnicka-Glubisz A, Noonan FP. Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model. Photochem Photobiol Sci 2006; 5: 254-260.
19. Cancer Genome Atlas Network, Genomic Classification of Cutaneous Melanoma. Cell 2015; 161: 1681-1696.
20. Ikehata H, Ono T. The mechanisms of UV mutagenesis. J Radiat Res 2011; 52: 115-125.
21. Besaratinia A, Synold TW, Xi B, Pfeifer GP. G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells. Biochemistry 2004; 43: 8169-8177.
22. Robert C, Muel B, Benoit A, Dubertret L, Sarasin A, Stary A. Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. J Invest Dermatol 1996; 106: 721-728.
23. Besaratinia A, Kim SI, Pfeifer GP. Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J 2008; 22: 2379-2392.
24. Otoshi E, Otoshi E, Yagi T, Mori T, Matsunaga T, Nikaido O et al. Respective roles of cyclobutane pyrimidine dimers, (6-4)photoproducts, and minor photoproducts in ultraviolet mutagenesis of repair-deficient xeroderma pigmentosum A cells. Cancer Res 2000; 60: 1729-1735.
25. Bryan DS, Ransom M, Adane B, York K, Hesselberth JR. High resolution mapping of modified DNA nucleobases using excision repair enzymes. Genome Res 2014; 24: 1534-1542.
26. Su DG, Taylor JS, Gross ML. A new photoproduct of 5-methylcytosine and adenine characterized by high-performance liquid chromatography and mass spectrometry. Chem Res Toxicol 2010; 23: 474-479.
27. Giglia-Mari G, Sarasin A. TP53 mutation in human skin cancers. Hum Mutat 2003; 21: 217.
28. Jia P, Pao W, Zhao Z. Patterns and processes of somatic mutations in nine major cancers. BMC Med Genomics 2014; 7: 11.
29. Ikehata H, Higashi S, Nakamura S, Daigaku Y, Furusawa Y, Kamei Y et al. Action spectrum analysis of UVR genotoxicity for skin: the border wavelengths between UVA and UVB can bring serious mutation loads to skin. J Invest Dermatol 2013; 133: 1850-1856.
30. Mitchell DL, Paniker L, Douki T. DNA damage, repair and photoadaptation in a Xiphophorus fish hybrid. Photochem Photobiol 2009; 85: 1384-1390.
31. Pattison DI, Davies MJ. Actions of ultraviolet light on cellular structures. EXS 2006; 96: 131-157.
32. Mitchell DL, Nairn RS. The biology of the (6-4) photoproduct. Photochem Photobiol 1989; 49: 805-819.
33. Jans J, Garinis GA, Schul W, van Oudenaren A, Moorhouse M, Smid M et al. Differential role of basal keratinocytes in UV-induced immunosuppression and skin cancer. Mol Cell Biol 2006; 26: 8515-8526.
34. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B 2001; 63: 88-102.
35. Song Q, Cannistraro VJ, Taylor JS. Synergistic modulation of cyclobutane pyrimidine dimer photoproduct formation and deamination at a TmCG site over a full helical DNA turn in a nucleosome core particle. Nucleic Acids Res 2014; 42: 13122-13133.
36. Malcikova J, Smardova J, Rocnova L, Tichy B, Kuglik P, Vranova V et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. Blood 2009; 114: 5307-5314.
37. Selvanayagam CS, Davis CM, Cornforth MN, Ullrich RL. Latent expression of p53 mutations and radiation-induced mammary cancer. Cancer Res 1995; 55: 3310-3317.
38. Carsten MJ, Krempler A, Triplett AA, Van Lohuizen M, Wagner KU. Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biol Chem 2004; 279: 35984-35994.
39. Slovackova J, Grochova D, Navratilova J, Smarda J, Smardova J. Transactivation by temperature-dependent p53 mutants in yeast and human cells. Cell Cycle 2010; 9: 2141-2148.
40. Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P, Kaur B et al. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. Cancer Res 2002; 62: 2897-2905.
41. Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell Rep 2013; 3: 246-259.